BRIDGE-IT

Emergency contraception (EC) is a tablet that can prevent pregnancy following unprotected sex. Most women in the UK go to a pharmacy for EC. It is important to start a regular method of contraception after EC, but most pharmacies cannot provide this without a prescription. This means that women must then go to a GP or a family planning clinic and some fall pregnant during this time.

The aim of this study is to find out whether pharmacists should give a supply of the progestogen only pill (POP) along with EC to women as temporary contraception until they can get to a clinic.

Chief Investigator: Professor Sharon Cameron

Number and location of participating sites (by region/ country): UK: 31 pharmacy sites in Scotland and England

ISRCTN number:  70616901;

ISRCTN website link: https://www.isrctn.com/ISRCTN70616901

Image

Funder:  HTA/NIHR

Start and End date

Of grant award: 01/04/2017 to 30/03/2020

Of recruitment: 16/12/2017 - 30/06/2019

Current status: Published

We are pleased to announce that the results of the Bridge-it Study have been published in the Lancet and the full publication is available online.

Please find the article at:-https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31785-2/fulltext

Website: https://w3.abdn.ac.uk/hsru/BRIDGE-IT/Public/Public/index.cshtml

UK GDPR Privacy Statement: If you have participated in this study and would like to read how it complies with UK GDPR, please read this document.

Sponsor: ACCORD  http://www.accord.ed.ac.uk/

Chief Investigator: Professor Sharon Cameron, Clinical Lead for Sexual and Reproductive Health Services, NHS Lothian, Chalmers Centre, 2a Chalmers Street, Edinburgh EH3 9ES; Email: Sharon.Cameron@ed.ac.uk

Trial Manager: Claire Battison;  Edinburgh Clinical Trials Unit, Usher Building, The University of Edinburgh, 5‒7 Little France Road, Edinburgh BioQuarter ‒ Gate 3, Edinburgh EH16 4UX

Email: Bridge-IT@ed.ac.uk

ECTU Involvement: Trial Management